EUVIMEDEUVIMED entdecken
Crossref

Usage of oral vancomycin for acute Clostridioides difficile infection (CDI) resulting in later acquisitions of vancomycin-resistant enterococci (VRE)

Evgeny Rogozin iD, Husam Maree, Majdi Masarwi iD, Rozan Hasona, Herschel T Horowitz, Ruth Bouganim, Dror Marchaim iD

Infection Control & Hospital Epidemiology · 2025-07 · 46 (7) · 703-709

DOI: 10.1017/ice.2025.81 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection Control & Hospital Epidemiology, online erschienen am 16.05.2025. Verfasst von Evgeny Rogozin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel. Hauptthemen laut MEDLINE: Vancomycin, Vancomycin-Resistant Enterococci, Clostridium Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Therapeutic guidelines for Clostridioides difficile infections (CDI) were revised a few years ago, promoting the usage of oral vancomycin even for primary mild infections. Vancomycin-resistant enterococci (VRE) is one of the worldwide most significant pathogens. Our study aim was to explore the independent association between oral vancomycin treatment for CDI, and subsequent VRE acquisitions.

Design

Retrospective cohort study.

Setting

Academic 904-bed general hospital (Shamir Medical Center, Israel). Patients: Adult (>18 yr) inpatients with primary CDI and no prior VRE.

Methods

Study was conducted for calendar years 2016-2020. Logistic regression was used to model-independent predictors for VRE acquisitions. A propensity score (PS)-matched analysis (logistic regression) of the risk of receiving oral vancomycin was conducted to further eliminate potential confounders.

Results

Overall, 606 patients were included (54% females), with a median age of 75 (IQR = 65–85) years. Independent predictors for VRE acquisition were oral vancomycin as a main therapy (aOR = 4.3, P < 0.001), exposure to systemic vancomycin in the previous 3 months (aOR = 3.2, P < 0.001), dependent functional status (aOR = 2.3, P = 0.006), and diabetes (aOR = 1.8, P = 0.04). After controlling for the PS, the independent association between oral vancomycin and later VRE acquisition remained significant in the regression model (aOR = 3.6, P < 0.01) and per PS matched-pairs analysis (aOR = 4.4, P < 0.01).

Conclusion

Oral vancomycin administered for CDI had a strong independent association with later VRE acquisitions. This finding could promote stewardship interventions in an effort to reduce the usage of oral vancomycin for certain CDI indications, leading to improved CDI management, while curbing the continued emergence of VRE at hospitals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinVancomycin-Resistant EnterococciClostridium InfectionsAnti-Bacterial AgentsGram-Positive Bacterial InfectionsHumansRetrospective StudiesFemaleAgedMaleAged, 80 and overAdministration, OralIsraelClostridioides difficileLogistic ModelsMiddle AgedCross InfectionRisk Factors

Substanzen

VancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel.
  • Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.

ORCID-Profile: Evgeny Rogozin, Majdi Masarwi, Dror Marchaim

Zitieren

APA

Rogozin, E., Maree, H., Masarwi, M., Hasona, R., Horowitz, H. T., Bouganim, R., & Marchaim, D. (2025). Usage of oral vancomycin for acute Clostridioides difficile infection (CDI) resulting in later acquisitions of vancomycin-resistant enterococci (VRE). Infection Control & Hospital Epidemiology, 46(7), 703-709. https://doi.org/10.1017/ice.2025.81

Vancouver

Rogozin E, Maree H, Masarwi M, Hasona R, Horowitz HT, Bouganim R, et al. Usage of oral vancomycin for acute Clostridioides difficile infection (CDI) resulting in later acquisitions of vancomycin-resistant enterococci (VRE). Infection Control & Hospital Epidemiology. 2025;46(7):703-709. doi:10.1017/ice.2025.81

BibTeX
@article{Rogozin2025,
  author = {Rogozin, Evgeny and Maree, Husam and Masarwi, Majdi and Hasona, Rozan and Horowitz, Herschel T and Bouganim, Ruth and Marchaim, Dror},
  title = {Usage of oral vancomycin for acute Clostridioides difficile infection (CDI) resulting in later acquisitions of vancomycin-resistant enterococci (VRE)},
  journal = {Infection Control & Hospital Epidemiology},
  year = {2025},
  volume = {46},
  number = {7},
  pages = {703--709},
  doi = {10.1017/ice.2025.81}
}
Kostenlos starten →